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Abstract
Introduction: Synovial fibroblasts (SF) undergo phenotypic changes in rheumatoid arthritis (RA) that contribute to
inflammatory joint destruction. This study was undertaken to evaluate the clinical and functional significance of ectopic
podoplanin (gp38) expression by RA SF.
Methods: Expression of gp38 and its CLEC2 receptor was analyzed by immunohistochemistry in synovial arthroscopic
biopsies from RA patients and normal and osteoarthritic controls. Correlation between gp38 expression and RA
clinicopathological variables was analyzed. In patients rebiopsied after anti-TNF-a therapy, changes in gp38 expression were
determined. Platelet-SF coculture and gp38 silencing in SF were used to analyze the functional contribution of gp38 to SF
migratory and invasive properties, and to SF platelet crosstalk.
Results: gp38 was abundantly but variably expressed in RA, and it was undetectable in normal synovial tissues. Among
clinicopathologigal RA variables, significantly increased gp38 expression was only found in patients with lymphoid
neogenesis (LN), and RF or ACPA autoantibodies. Cultured synovial but not dermal fibroblasts showed strong constitutive
gp38 expression that was further induced by TNF-a. In RA patients, anti-TNF-a therapy significantly reduced synovial gp38
expression. In RA synovium, CLEC2 receptor expression was only observed in platelets. gp38 silencing in cultured SF did not
modify their migratory and invasive properties but reduced the expression of IL-6 and IL-8 genes induced by SF-platelet
interaction.
Conclusions: In RA, synovial expression of gp38 is strongly associated to LN and it is reduced after anti-TNF-a therapy.
Interaction between gp38 and CLEC2 platelet receptor is feasible in RA synovium in vivo and can specifically contribute to
gene expression by SF.
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Introduction
Synovial fibroblasts (SF) are a heterogeneous cell population
that represents the main resident cell component of synovial tissue.
In rheumatoid arthritis (RA), SF expand and undergo phenotypic
changes that contribute to the pathogenesis of chronic arthritis [1–
3]. SF can respond to cytokines and, they maintain prolonged
changes on the expression of genes involved in persistent
inflammation and joint destruction in RA [4–6]. Crosstalk
between SF and myeloid and lymphoid cell seems critical for
persistent recruitment, survival and activation in chronic inflam-
mation. These functions are associated to specific SF properties
that resemble those of stromal cells in lymphoid tissues [7–10].
Lymphoid stromal cells play critical roles for the physiological
trafficking and anatomico-functional compartmentalization of
immune cells that supports normal immune responses [11,12].
Among the shared lymphoid and RA stromal features, the
expression of the surface glycoprotein podoplanin or gp38 has
been reported [12–14]. gp38 expression is normally restricted to
lymphatic endothelium and in lymphoid organs, to stromal cells of
the T-cell zone. Aberrant expression of gp38 in fibroblasts has also
been observed in other pathological tissues where fibroblasts play
diverse roles in cancer progression or fibrosis [12,15,16]. gp38(+)
fibroblasts might emerge in inflammatory tissues due to either
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specific cell proliferation of local gp38(+) progenitors or to induced
expression in gp38(2) fibroblasts by inflammatory cytokines
[14,16,17]. In a murine model of experimental autoimmune
encephalomyelitis, a gp38 antagonist reduced inflammation-
associated lymphoid neogenesis (LN) pointing to additional
functions for gp38 in inflammation, although the precise
mechanism remains unknown [18].
In cancer epithelial cells undergoing epithelial-mesenchymal
transformation, gp38 expression confers enhanced cell migration
and tumour invasiveness, consistently with the observation of gp38
up-regulation on the invasive front of tumors [19,20]. In cultured
lymphatic endothelium gp38 knockdown has also shown to reduce
cell migration by regulating the activities of RhoA and Cdc42
GTPases [21]. This effect has been studied ex vivo and it seems
mediated by indirect mechanisms of intracellular interaction
between gp38 intracellular domains and ERM proteins ezrin
and moesin that result in modification of small GTPase activities
involved in cancer cell motility. Whether gp38 can modify cell
motility in stromal cells of lymphoid organs or in inflammatory
fibroblasts is not known.
The physiological and developmental functions of gp38 have
been dissected in knockout mice. gp38 lacks intracellular signalling
domains and its function seems to depend on its monogamous
signalling receptor CLEC2. gp38 and CLEC2 knockout mice
display an identical phenotype characterized by an embryonary
defect in blood-lymphatic vascular separation [22–24]. In mice,
CLEC2 is only expressed by platelets and some myeloid cell types,
notably dendritic cells (DC) [25]. gp38 triggering of CLEC2
receptor induces platelet activation through Syk and SLP-76
signaling and this pathway seems critical for blood-lymphatic
vessels partitioning during development [26,27]. Crosstalk be-
tween lymphoid endothelial cells and platelets involves CLEC2
receptor triggering by gp38 and the release of specific platelet
mediators that induce paracrine effects on endothelial cells [27].
To analyze the significance of increased gp38 expression in RA,
we analyzed its correlation with clinical and pathological variables
of the disease in a series of RA synovial tissues, including serial
samples obtained before and after anti-TNF-a therapy. We also
investigated the function of gp38 in SF by mean of RNA
interference in different models of cell migration and platelet
interaction relevant to RA pathogenesis.
Material and Methods
Patients and synovial biopsies
Synovial tissues were obtained from arthroscopic biopsies from
the knee of patients who fulfilled the American Rheumatism
Association revised criteria for RA (n = 38) [28]. All patients had
active disease characterized by inflammation of at least one knee
joint. Patients characteristics at biopsy were recorded and are
shown in Table 1.
Osteoarthritis (OA) synovial tissues were obtained by synovec-
tomy at prostetic join replacement surgery (n = 15, age: 68621,
60% female) and histologically normal synovial tissues were
obtained from healthy individuals without joint disease at elective
arthroscopy for minor traumatic lesions (n = 6, age 59619, 60%
female). In a subgroup of patients (n = 16), a second biopsy was
obtained after at least 6 months of anti-TNF-a therapy. The study
was approved by ethics committees of Hospital Clinic, Barcelona,
and Hospital 12 de Octubre, Madrid, and a written informed
consent was obtained from all patients.
Immunolabeling of cells and synovial tissues
Immunohistochemical (IHC) staining was performed using a
standard indirect avidin-biotin peroxidase method (ABC standard;
Vector Laboratories, Burlingame, CA, USA) and developed by
diaminobenzidine chromogen. The following antibodies and
matched isotype controls were used: anti-gp38 mAb (D2/40
IgG1 clone, Dako, Glostrup, Denmark) [29], anti-CD61 mAb
(SZ21 IgG1clone, Immunotech, Marseille, France), and anti-
CLEC2 polyclonal goat Ab (R&D Systems, Minneapolis, MN,
USA). Pretreatments included 10 mg/ml proteinase K (Sigma-
Aldrich Quimica SA, Madrid, Spain) for CD61 detection, and
microwave heating in 1 mM EDTA pH 8 for gp38 and CLEC2
detection. Double CLEC2 and CD61 immunofluorescent labeling
was performed using sequential incubation with anti-goat IgG
Alexa-Fluor 488 (green) and anti-mouse IgG1 Alexa-Fluor 594
(red) secondary antibodies (Invitrogen Molecular Probes, Eugene,
OR, USA).
Synovial tissue sections were photographed and digitalized
using a Spot RT CCD camera and Spot 4.0.4 software (Diagnostic
Instruments, Sterling Heights, Michigan) on a Zeiss Axioplan-2
fluorescence microscope (Zeiss, Jena, Germany). gp38 immuno-
peroxidase stainned fractional area was quantified using ImageJ
software (http://rsb.info.nih.gov/ij). IHC analysis and quantifica-
tion of CD3, CD20 CD68, hsp47, CD31 in RA synovial biopsies
as well as characterization of lymphoid neogenesis was performed
as previously described [30,31].
Fibroblasts grown on glass coverslips were immunolabeled with
anti-gp38 mAb (D2/40 clone, Dako). Detection was performed
with goat anti-mouse IgG1 Alexa-Fluor 594 labeled antibody and
DAPI counterstaining. Photographs were obtained on a Zeiss
LSM 510 META confocal microscopy (Zeiss).
Flow cytometric analysis of gp38 expression in cultured
fibroblasts was performed with anti-gp38 mAb (clone 18H5,
Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA) [32] and
goat anti-mouse IgG Alexa-Fluor 647 (Invitrogen Molecular
Probes). Cells were analyzed on a BD FACSCalibur instrument
(Becton Dickinson, San Jose´, CA, USA).
SF cultures and lentiviral siRNA transduction of
fibroblasts
SF and normal dermal fibroblast (DF) cultures were established
by explant growth of small biopsy fragments in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% heat
inactivated fetal bovine serum (FBS) (Lonza, Verviers, Belgium)
and used after 3rd passage.
A small-interfering RNA (siRNA) targeting human gp38 and a
scrambled non-silencing construction in pGIPz vector lentiviral
were purchased from Open Biosystems (Thermo Fisher Scientific,
Waltham, MA, USA). Lentiviral particles were obtained by co-
transfection of 293T cells with pGIPz transfer vector, pPAX2
packaging vector, and pMD2-VSVg envelope vector as previously
described [33]. Supernatants were harvested 48 hours after
transfection, filtrated through a 0.45 mm filter and diluted 1/2 in
DMEM medium for fibroblast transduction. Silencing efficiency
was monitored by analyzing gp38 mRNA and protein expression
by qRT-PCR and flow cytometry.
SF migration and invasiveness studies
SF migration was analyzed in wound-healing assays. Cells were
grown to confluence on culture chambered coverglasses (Lab-Tek
II 4, NUNC, Rochester, NY, USA) and a wound was made by a
single scrape using a sterile pipette tip. The wound area was
sequentially photographed at 0, 18 and 24 h. The area covered by
gp38 Expression and Functions in Synovial Fibroblasts
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cells migrating into the wound area was determined using ImageJ
software as the average closed area of the wound at 18 and 24 h
after scraping.
The invasive capability of RA SF was analyzed using a matrigel
coated transwell system (BioCoat Growth Factor Reduced
Matrigel Invasion Chamber, Becton Dickinson). SF were resus-
pended in DMEM 0.1% BSA, plated on the upper chamber of the
transwell insert (8 mm pores) and allowed to migrate through the
matrigel matrix membrane for 4 days. DMEM with 10% FBS and
10% human serum was added to the bottom well and used as
chemoattractant. The membrane was fixed with 4% paraformal-
dehyde and stained with DAPI for direct fluorescent microscopy.
Ten random fields per membrane were photographed and
digitalized and the number of cells per area was counted using
ImageJ software.
The capacity of SF to invade cartilage was indirectly determined
as the release of glycosaminoglycan (GAG) degradation products
from cartilage SF cocultures. Fresh frozen human cartilage slices
of fixed diameter and height (662 mm) were collected from
cartilage obtained during joint replacement surgery for hip
fracture and attached to 24-well plates. SF were dropwise added
on top of the slices. After incubation for 3 h at 37uC and 5% CO2,
wells were filled with 1 ml DMEM 10% FBS. Supernatants were
removed after 4 and 7 days of culture and GAG determined using
Blyscan assay (Biocolor Ltd, Belfast, N. Ireland) according to the
manufacturer’s protocols.
SF platelet co-cultures
Platelets were isolated from peripheral whole blood in EDTA
from healthy donors. Platelet-rich plasma (PRP) was obtained by
centrifugation at 150 g at room temperature for 10 minutes.
Platelets were pelleted, resuspended on DMEM and added to SF
cultures at 1:1000 ratio (SF:Platelets). SF were seeded into 6-well
plates in 1% FBS DMEM one day before platelet co-culture. Co-
cultures were maintained at 37uC for 5 h. Cells and supernatants
were collected for RNA and protein quantification. Parallel SF
cultures without platelets were established and used as controls.
Quantitative Real Time-PCR (qRT-PCR) of RNA extracts
from SF was carried out on Applied Biosystems 7500 Fast Real-
Time PCR System using either Power Sybr Green PCR Master
Mix or TaqMan Gene Expression assays (Applied Biosystems).
The sequences of PCR primers used are listed in Table S1. For
relative quantification, we calculated the amount of target gene
normalized to the endogenous reference gene (b-actin) using 2-
DDCt formula, where Ct is the mean of threshold cycle at which the
amplification of the PCR product is first detected. We performed a
previous validation experiment comparing the standard curve of
the reference and the target to demonstrate that the primers
efficiencies were approximately equal.
IL-6 concentration in supernatants from SF platelets co-cultures
was determined by ELISA (Biolegend Inc, San Diego, CA, USA).
Statistical Analysis
Data were analyzed using Prism software v5.0 (GraphPad
Software, San Diego, CA, USA). Results are expressed as
mean6SD and means were compared by Student’s t-test,
Mann-Whitney U-test, and Wilcoxon tests as appropriate.
Correlation between different numerical variables was analyzed
by Spearman’s or Pearson’s tests as appropriate. Categorical
variables were analyzed by Chi-square test. In all experiments, p
value ,0.05 was considered statistically significant.
Results
Clinicopathological correlates of gp38 expression in RA
synovial tissues
To extend previous observations by Ekwall et al in advanced RA
disease undergoing joint replacement [14], to RA patients biopsied
at earlier stages, we performed quantitative IHC analyses in
arthroscopic biopsies from a series of RA patients with active
arthritis of the knee, heterogeneous regarding other characteristics
of the disease (Table 1). Abundant gp38 expression was observed
in synovial lining and sublining fibroblasts in RA biopsies (n = 38),
whereas minimal expression was observed in OA (n = 15), and it
was undetectable in normal synovial tissues (n = 6). In all RA
Table 1. Clinicopathological data of RA patients at biopsy.*
RA characteristics
Age, years 60.6612.5 [40–89]
Female 61.8%
RA duration, months 103.26111.4 [4–441]
CD3+T cells/mm2 7366557 [9–2374 ] 2374 range]
CD20+B cells/mm 2826265 [2–1040]
CD68+cells/mm2 226761416 [45–1016]
DAS28 5.261.5 [2.34–8.35]
Lymphoid neogenesis positive (%) 63.9%
CRP (mg/dl) 3.562.8 [0.1–10.1]
Erosive disease 79.4%
RF positive{ 61.2%
ACPA positive{ 80.6%
Previous DMARD 100%
Previous anti-TNF-a 48.6%
*Quantitative data are expressed as mean6SD and [range]. CRP, C-reactive protein; DAS28, 28-joint Disease Activity Score; DMARD, disease-modifying antirheumatic
drug; {RF.30 IU/ml; anti-citrullinated protein antibodies ACPA.50 IU/ml.
doi:10.1371/journal.pone.0099607.t001
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tissues, gp38 was observed in lining cells, whereas in 54% of the
cases it extended to sublining fibroblasts, and stromal cells within
LN structures (Figure 1A). Lymphatic gp38(+) vessels were
extremely rare in the superficial lining and sublining areas used
for quantitative evaluation, but were readily observed in deeper
tissues.
The level of gp38 expression in RA, expressed as the fractional
labeled area, did not correlate with age, disease duration, activity
evaluated as DAS28, C-reactive protein, macrophagic, T-cell or
B-cell infiltration, and fibroblast or vascular density (data not
shown). gp38 expression was found significantly increased in the
group of patients (64%) with ectopic LN (Table 2). We also found
significantly increased gp38 expression in the groups of patients
with rheumatoid factor or anti-citrullinated protein (ACPA)
autoantibodies compared to seronegative patients (Table 2). No
correlation between LN and the presence of autoantibodies was
found.
In a subgroup of 16 patients that initiated therapy with a TNF-a
antagonist after biopsy, we analyzed the changes in gp38
expression after therapy. In synovial tissues obtained after
12.3614.1 months of anti-TNF-a therapy, a significant reduction
in gp38 expression compared to pretreatment tissues was observed
(20.269.0% to 6.966.0%, p = 0.0001) (Figure 1B). EULAR good
or moderate responses [34] had been achieved in 12 of 16 patients
at second biopsy. A lower decrease on gp38 expression in the
second biopsy was observed in non-responders but the difference
was not statistically significant.
gp38 expression and function in cultured fibroblasts
Cultured SF displayed abundant gp38 expression irrespective of
their source (RA, OA or healthy synovium) but this was not a
general feature of cultured human fibroblasts since DF did not
show gp38 expression (Figure 2). Membrane expression of gp38
was also confirmed by labeling of unpermeabilized SF by flow
cytometry and confocal microscopy (Figure 2). Treatment of
cultured SF with TNF-a induced a significant up-regulation of
gp38 mRNA and protein expression, as determined by qRT-PCR
(data not shown) and flow cytometry (Figure 2). In cultured DF,
TNF-a also induced gp38 mRNA and protein expression but to a
lower extent compared to SF.
To analyze the potential role of gp38 on the cell behaviour of
SF, we performed RNA interference experiments in cultured RA
fibroblasts. In SF transduced with a lentiviral gp38-specific siRNA
construct, a profound downregulation of gp38 mRNA and
Figure 1. Expression of gp38 in synovial tissues. (A) IHC immunoperoxidase labelling of gp38 expression in normal, OA and RA tissues. RA
CTRL: IgG1 isotype control. Lining and sublining areas, and a large lymphoid aggregate centered by a HEV (arrows) are shown. Bar: 50 mm. Original
magnification 400x (B) Changes in gp38 expression after anti-TNF therapy. Representative imunoperoxidase labeling of gp38 of a single patient pre-
and post-treatment. Bar: 100 mm. Original magnification 200x (C) Mean6SD gp38 immunostained fractional area in the different groups (OA vs RA
Mann Whitney test *p,0.0001), and in basal (Pre) and post-anti-TNF-a therapy (Post) in 16 patients (RA Pre vs RA Post Wilcoxon matched-pairs signed
rank test *p,0.0001).
doi:10.1371/journal.pone.0099607.g001
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membrane protein was observed compared to control siRNA
transduced SF (Figure S1A). Cell viability was similar in gp38
(82.51615.29%) and control (84.09611.88%) transduced cells.
Since the best described function of gp38 is a gain of function in
cell migratory and invasive properties of epithelial cancer cells
[19,20], we compared cell migration and invasive capacities of SF
transduced with gp38 or control siRNA lentivirus. Cell migration
through matrigel coated transwells was similar in gp38 silenced
and control SF (Figure S1B). Invasion of wound area on plastic
monolayer was also similar in gp38 silenced or control SF (Figure
S1C), therefore excluding a relevant function for gp38 in cell
adhesion and motility on matrigel or plastic surfaces in SF.
Previous studies have shown that RA SF attach and invade the
cartilage causing degradation of the extracellular matrix. There-
fore, to analyze the invasive capacity of SF in a model relevant to
RA, SF were seed onto human cartilage slices [35,36]. Transduced
RA SF expressing GFP and siRNA efficiently attached and
invaded cartilage ex vivo, as observed by direct fluorescent
microscopy, and induced an increase on GAG release to the
media. GAG release at 4 and 7 days after SF seeding was similar in
gp38 silenced compared to control RA SF, excluding an important
role for gp38 membrane expression in this process (Figure S1D).
CLEC2 expression in RA synovial tissues
To identify expression of CLEC2 receptor in cells potentially
interacting with gp38(+)SF, we performed IHC studies in RA
synovial tissues. CLEC2 expression was only detected in small
particles or aggregates lacking nuclei located in intra- and
perivascular areas of the sublining area. In some cases, CLEC2
positive aggregates were associated to amorphous fibrin deposits
attached to the lining surface. In these locations we demonstrated
the presence of platelets by specific CD61 IHC (Figure 3). Double
immunofluorescent labeling confirmed colocalization of CLEC2
and CD61(+) platelets (Figure S2).
Although IHC observations did not support CLEC2 expression
by myeloid cells, to exclude lower levels of gp38 signalling receptor
CLEC2 expression in human myeloid DC as recently described in
murine DC [21], we performed western blot analysis of platelet
and human DC under different maturation and activation status.
Our data confirmed CLEC2 expression in platelet extracts but
failed to detect CLEC2 in human DC (Figure S3). By flow
Table 2. Clinicopathological correlations of gp38 expression* in RA synovial tissue.
RA variables gp38 expression* p value
RF(+/2) 20.1610.6/13.067.9 0.0078
ACPA(+/2) 20.4610.2/12.367.9 0.0450
LN(+/2) 21.9610.4/10.665.6 0.0004
Erosive disease(+/2) 18.9610.6/15.068.0 0.22
Earlier disease"(+/2) 19.567.4/18.2610.8 0.55
*Fractional immunolabeled gp38 area (%, mean6SD). RF, rheumatoid factor; ACPA; Anti-citrullinated protein antibodies; LN, lymphoid neogenesis. "Patients with RA
duration less than 1 year. Mean6SD.
doi:10.1371/journal.pone.0099607.t002
Figure 2. gp38 expression of cultured synovial fibroblasts. SF from RA, OA and normal synovial tissues, and normal skin dermal fibroblasts
(DF) were cultured on glass coverslips and immunolabeled (red) for gp38 expression. TNF-a treated DF cultures are also shown (DAPI nuclear
counterstaining). Flow cytometric detection of surface gp38 by in RA SF and DF untreated (basal) or treated with TNF-a for 24h. Data are
representative of 6 SF and 3 DF lines (*p= 0.03 basal vs TNF-a treated). MFI: Mean fluorescence intensity.
doi:10.1371/journal.pone.0099607.g002
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cytometry, we also failed to detect binding of gp38-Fc protein to
mature or immature DC (data not shown).
gp38 function in fibroblast CLEC2 platelet interaction
Since CLEC2 was not detected in any other cellular element of
RA synovium, we focused on platelet SF functional interactions to
analyze the potential function of gp38 in this system. Gene
expression of cytokines, chemokines and metalloproteinases factors
previously associated to proinflammatory or tissue destructive
functions of RA SF was analyzed in SF platelet co-cultures
compared to parallel SF cultures in the absence of platelets.
Platelet co-culture induced a strong increase in the expression of
IL-6 and the chemokines IL-8, CXCL2 and CXCL3 mRNA
(Figure 4A), whereas MMP (MMP-1, MMP-3 and MMP-9
mRNA) and LN stroma related factors were non-significantly
increased (IL-7, CXCL13 mRNA) or decreased (CCL21 mRNA)
(data not shown).
In platelet cocultured SF, gp38 silencing significantly reduced
IL-6 and IL-8 mRNA expression, whereas CXCL2 and CXCL3
mRNA expression was not significantly modified (Figure 4A).
Protein levels of IL-6 in the supernatant of SF platelet co-cultures
were also significantly reduced in gp38 silenced SF compared to
non-silenced controls (Figure 4B).
Discussion
Our data confirm that fibroblast gp38 expression is character-
istic of RA inflammatory tissue, in contrast to normal synovial
tissue, where it is undetectable. Interestingly, regardless in vivo
expression, both normal and arthritic SF acquire similar
membrane gp38 expression in culture. Therefore, exposure to
growth factors and tissue culture conditions seem to induce gp38
in normal SF that do not express the protein in vivo but not in
normal DF pointing to different tissue-specific fibroblast pheno-
Figure 3. Detection of CLEC2 expression in synovial tissues. IHC immunoperoxidase labelling of CLEC2 receptor and CD61 (platelets) in OA,
RA and normal synovial tissues as indicated. Non immune serum control for anti-CLEC2 IHC is also shown (RA CTRL). Bar: 50 mm. Original
magnification 400x.
doi:10.1371/journal.pone.0099607.g003
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types. TNF-a and inflammatory cytokines may also induce gp38
expression in SF as previously reported [14] but again at much
higher levels in SF compared to DF. Therefore, the higher
capacity of SF to express gp38 represents a tissue specific property
potentially relevant to their participation in joint specific
inflammatory diseases. Recent studies have identified the prolif-
eration of specific perivascular stromal precursors characterized by
constitutive expression of gp38 and ADAM12 as the source of
gp38 fibroblasts in different inflammatory mouse models [16,17].
We failed to detect perivascular gp38(+) cells in human healthy
skin (data not shown) and normal synovium. This observation,
together with the uniform acquisition of gp38 expression by
cultured SF and its induction by TNF-a, suggest that growth factor
or cytokine induced expression may underlie the observed gp38
stromal expansion in RA synovium. In addition, gp38 was
significantly downregulated in patients treated with TNF-a
antagonists further supporting this mechanism.
The expression of gp38 in RA tissues from patients with
advanced destructive disease had suggested its potential role in
structural damage [14]. We have also identified high gp38
expression in patients at earlier phases of the disease, excluding
a correlation between disease progression and the level of gp38
expression and indicating that gp38 expression may be an early
feature in RA. No significant correlations between the level of
gp38 expression and most clinical or pathological RA features
were found, with the striking exceptions of LN and RA
autoantibodies positive groups. The finding of increased gp38
expression in patients with synovial LN, together with the previous
observation of defective lymphoid development in gp38 deficient
mice, point to a mechanistic link between both processes [18]. In
several mouse models of inflammation also characterized by LN,
the expansion of gp38(+) fibroblasts has been demonstrated [17].
The dependence of inflammatory LN on gp38 has been
demonstrated in the mouse model of autoimmune encephalomy-
elitis, where anti-gp38 antibodies abrogated LN development [18].
However, the role of gp38(+)stromal cells is uncertain in that
study, since gp38 expression and function was attributed to Th17
cells.
Whether ontogenic or pathological LN is dependent on
functional gp38/CLEC2 receptor interaction is unknown. Such
interaction is feasible in RA, where we observed both gp38(+) SF
and CLEC2(+) platelets in the synovial tissue. Previous studies had
also demonstrated the presence of abundant platelet microparticles
in the synovial fluid of patients with RA ant their capacity to
induce potent paracrine proinflammatory effects on SF [37,38].
Platelets respond to CLEC2 triggering by phosphorylating its
cytoplasmic immunoreceptor tyrosine-based activation motifs
(ITAM) which, in turn, recruits and activates tyrosin kinases
Syk/Btk resulting in platelet activation. This process leads to the
generation of platelet microparticles and the release of mediators
stored in platelet granules such as IL-1 with potent paracrine
effects on SF [27,38]. ITAM-dependent platelet activation may
also be induced by GPVI receptor and therefore, both pathways
might participate in platelet-stromal inflammatory crosstalk.
CLEC2 specific effects, not triggered by GPVI receptor activation,
have been proposed using CLEC2 deficient platelets but are
difficult to dissect out in inflammatory models where platelet
activation is required to maintain vascular integrity [27,39].
Our data confirm that platelet-SF co-culture induces strong
changes in the expression of multiple genes by SF, similar to those
induced by platelet microparticles [37,38]. Among these genes, IL-
6 and IL-8 were specifically reduced by gp38 silencing in SF in
contrast with other platelet-induced genes, providing evidence of a
contribution of CLEC2 to proinflammatory platelet-SF crosstalk.
IL-6 plays a pivotal role in RA pathogenesis and its therapeutic
targeting is highly effective in modifying the course of the disease
[40]. Although macrophagic cytokines IL-1b and TNF-a are also
potent stimuli for IL-6 expression in RA SF, our and previous data
suggest that platelets may also play an important role [37].
However, the link between this observation and the potential role
of gp38 expression in rheumatoid LN is unclear. IL-6 has
pleiotropic functions on lymphoid cells including the development
of Th17 cells as well as T follicular helper and B cells involved in
the development of orthotopic germinal centres in autoimmune
arthritis but its influence on ectopic LN development is unknown
[41-43]. We did not detect gp38 dependent changes on the
expression of stromal factors associated to ontogenic or inflam-
matory LN such as IL-7 or lymphoid homing chemokines
CXCL13 or CCL21 [10,44].
Figure 4. Expression of cytokines and chemokines in gp38 silenced RA SF platelet co-cultures. (A) Magnitude of the up-regulation on IL-
6, IL-8, CXCL2 and CXCL3 mRNA expression induced by platelets and expressed as the ratio (FC) between SF and platelet co-cultures compared to
parallel SF only cultures in gp38 siRNA silenced SF and non-silenced controls (si-CTRL) as measured by qRT-PCR. (B) IL-6 protein levels in supernatants
of platelet cocultured gp38 siRNA silenced SF compared to non-silenced controls as measured by ELISA. Mean6SD data are representative of 3
independent experiments (*p = 0.0002, **p = 0.01, ***p,0.0001).
doi:10.1371/journal.pone.0099607.g004
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We failed to confirm an intrinsic role for gp38 in an ex vivo
model of SF invasion and cartilage degradation, in contrast to that
observed in cancer cells [19,20]. In cancer epithelial cells, gp38 is
associated to EMT, a process that provides mesenchymal cell
migratory properties to epithelial cells otherwise lacking motile or
invasive capacity. It is therefore possible that gp38 does not
provide these functionalities to fibroblasts which are highly mobile
cells. An alternative explanation is that siRNA silencing of gp38
expression is not complete and remaining gp38 expression might
be sufficient to maintain its function.
In conclusion, our study shows a new mechanism involved in
platelet-SF proinflammatory interactions in RA synovium, sup-
porting an important role for the acquisition of gp38 expression in
SF. We also identify a strong association between gp38 expression
and synovial LN, consistent with its reported role in developmental
and experimental LN, but the mechanistic basis of this association
requires further studies.
Supporting Information
Figure S1 Migratory and invasive capabilities of gp38
silenced RA SF. (A) Silencing efficiency of siRNA lentiviral
transduction of RA SF as analyzed by qRT-PCR (si-CTRL
mRNA gp38/b-actin ratio set to 100%) and flow cytometry
(percentage of gp38(+) RA SF is indicated, *p = 0.03). MFI: Mean
fluorescence intensity. (B) Invasive capability of RA SF on
matrigel coated transwells expressed as the number of cells per
field that migrated through the matrigel at 4 days. (C) SF
migration in wound assays expressed as the percentual closure of
the wound area 18 h and 24 h after scraping. A representative
image is shown (100x). (D) GAG release into the supernatant at 4
and 7 days of RA SF cartilage co-culture. Basal: GAG release by
cartilage in the absence of SF. A representative image of siRNA
GFP transduced SF attached to cartilage is shown (200x). Results are
representative of three independent experiments (NS: not significant).
(TIF)
Figure S2 Double CLEC2 and CD61 platelet labeling in
RA synovial tissues. Double green (CLEC2) red (CD61)
labeling with DAPI counterstaining is shown is shown in upper
row as indicated. Controls (CTRL) including only anti-CLEC or
only CD61 primary antibody and both secondary antibodies are
shown in lower rows as indicated. Bar 20 mm.
(TIF)
Figure S3 Western blot analysis of CLEC2 expression.
Platelets were obtained from healthy donors peripheral blood.
Immature DC (imDC) were derived from buffy coat monocytes
cultured for 7 days in complete RPMI medium containing GM-
CSF (1000 U/ml) and IL-4 (1000 U/ml). For maduration, imDC
were treated with LPS (1 mg/ml) or TNF-a (50 ng/ml) for 24 or
72 h respectively. Protein extracts (30 mg) are analyzed by western
blotting with anti-CLEC2 polyclonal antibody (R&D Systems) or
anti-b-actin mAb (Sigma), developed by peroxidase-conjugated
secondary antibodies and ECL system.
(TIF)
Table S1 Primer sequences used for quantitative real-
time PCR analysis.
(DOC)
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